Enrollment of 16 participants in the Phase 1b trial has surpassed the initial goal of 15 participants ahead of schedule. 90-day biomarker analysis results are now expected to be available in 4Q 2025, ...
As of June 30th, 16 participants have enrolled in the Phase 1b, ahead of the original goal of at least 15 total participants by 3Q 2025 Analysis of 90-day biomarker activity from cerebrospinal fluid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback